317 related articles for article (PubMed ID: 14972505)
1. Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus.
Meyer A; Kausch I; Krüger S; Fetscher S; Böhle A; Jocham D
Urology; 2004 Feb; 63(2):381-2. PubMed ID: 14972505
[TBL] [Abstract][Full Text] [Related]
2. [A case of hydronephrosis caused by renal stones with elevated serum levels of CA-19-9 and CA-125].
Ito S; Nishikawa K; Goto T; Tsujita M; Takegaki Y; Kishimoto T
Hinyokika Kiyo; 1994 Oct; 40(10):885-8. PubMed ID: 7992702
[TBL] [Abstract][Full Text] [Related]
3. Giant hydronephrosis due to a ureteral stone, and elevated serum levels of CA 19-9.
Shudo R; Saito T; Takahashi K; Horita K; Waku K; Honma I; Sato T
Intern Med; 1999 Nov; 38(11):887-91. PubMed ID: 10563751
[TBL] [Abstract][Full Text] [Related]
4. Case report of renal pelvic adenocarcinoma associated with a renal stone that produced carbohydrate antigen 125 and carbohydrate antigen 19-9.
Azumi M; Hou K; Numata A; Taniguchi N; Saga Y; Hashimoto H; Kakizaki H
Hinyokika Kiyo; 2007 Sep; 53(9):631-4. PubMed ID: 17933139
[TBL] [Abstract][Full Text] [Related]
5. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis.
Suzuki K; Muraishi O; Tokue A
J Urol; 2002 Jan; 167(1):16-20. PubMed ID: 11743265
[TBL] [Abstract][Full Text] [Related]
6. [Pelvic kidney associated with staghorn calculus and renal pelvic cancer: a case report].
Arisawa C; Fujii Y; Higashi Y; Owada F; Shimizu S; Kaneko K
Hinyokika Kiyo; 1995 Mar; 41(3):209-11. PubMed ID: 7741074
[TBL] [Abstract][Full Text] [Related]
7. [Squamous cell carcinoma of the renal pelvis with giant hydronephrosis].
Ujike T; Noda Y; Oka D; Takada S; Fujimoto N; Koide T; Kobayashi Y
Hinyokika Kiyo; 2003 Dec; 49(12):757-9. PubMed ID: 14978961
[TBL] [Abstract][Full Text] [Related]
8. Persistent elevation of serum CA 19-9 with no evidence of malignant disease.
Ventrucci M; Pozzato P; Cipolla A; Uomo G
Dig Liver Dis; 2009 May; 41(5):357-63. PubMed ID: 18602352
[TBL] [Abstract][Full Text] [Related]
9. [A case of CEA-producing renal pelvic and ureteral cancer].
Abe T; Konari S; Ogata M; Komatsu S; Satoh T
Hinyokika Kiyo; 2003 Feb; 49(2):75-9. PubMed ID: 12696186
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis.
Aybek H; Aybek Z; Sinik Z; Demir S; Sancak B; Tuncay L
Int J Urol; 2006 Nov; 13(11):1380-4. PubMed ID: 17083387
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic nephrectomy for giant staghorn calculus with non-functioning kidneys: is associated unsuspected urothelial carcinoma responsible for conversion? Report of 2 cases.
Shah HN; Jain P; Chibber PJ
BMC Urol; 2006 Jan; 6():1. PubMed ID: 16398940
[TBL] [Abstract][Full Text] [Related]
12. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9].
Kondoh K; Noguchi S; Shuin T; Masuda M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585
[TBL] [Abstract][Full Text] [Related]
13. [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report].
Kobori Y; Shigehara K; Amano T; Takemae K
Hinyokika Kiyo; 2005 Feb; 51(2):105-8. PubMed ID: 15773363
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of elevated levels of serum CA 19-9.
Pavai S; Yap SF
Med J Malaysia; 2003 Dec; 58(5):667-72. PubMed ID: 15190651
[TBL] [Abstract][Full Text] [Related]
15. False elevation of CA 19-9 levels in a patient with a history of pancreatic cancer.
Goetz M; Steen PD
Am J Gastroenterol; 1997 Aug; 92(8):1390-1. PubMed ID: 9260821
[TBL] [Abstract][Full Text] [Related]
16. Elevation of Ca 125 in a patient with giant congenital hydronephrosis.
El Khoury Moreno R; Dominguez Molinero JF; Rodríguez Rincón JP; Coterón Ochoa P; Coronil Belloso P; Gómez Velázquez M
Arch Esp Urol; 2013 Mar; 66(2):234-6. PubMed ID: 23589602
[TBL] [Abstract][Full Text] [Related]
17. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
[TBL] [Abstract][Full Text] [Related]
18. Elevated tumor marker CA 19-9 in the differential diagnosis of pancreatic mass lesions.
Cwik G; Wallner G; Skoczylas T; Krzyzanowski M; Ciechainski A; Madro P
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):213-8. PubMed ID: 16146081
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers.
Kokociñska D; Jarzab B; Król R; Ziaja K; Szejbak K; Kuśmierski S
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):283-7. PubMed ID: 9216823
[TBL] [Abstract][Full Text] [Related]
20. [A case of renal pelvic cancer with high serum level of CA 19-9].
Iwata H; Sugimoto T; Asai T; Kamikawa S; Kim T; Hayahara N; Nakatani T; Yamamoto K; Kishimoto T
Hinyokika Kiyo; 1998 Sep; 44(9):653-6. PubMed ID: 9805671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
